MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Model Number VAMF3636C200TE |
Device Problem
Activation, Positioning or Separation Problem (2906)
|
Patient Problems
Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/09/2024 |
Event Type
malfunction
|
Event Description
|
A valiant captivia stent graft was intended to be implanted during the endovascular treatment of a 300mm thoracic aortic dissection.It was reported that during the index procedure the stent was delivered to the designated location however it was found that during the release of the stent that the stent did not open normally so the stent was withdrawn.Another valiant captivia stent graft (vamf3838c200te) was implanted and the procedure completed successfully.Per the physician the cause of the deployment difficulties is undetermined.No additional sequelae were reported and the patients is fine.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Ime, imf coding corrected b5; additional information received : it was confirmed that when the slider handle was rotated , the graft cover would not retract to release the stent graft.No severe calcification was noted.The delivery system appeared normal when inspected prior to use.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|